🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
100 Servings
Amino acid/Protein Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 500mg

Other Ingredients

Gelatin Microcrystalline Cellulose Magnesium Stearate

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (100% of products) Structure/Function (90% of products) Nutrient (73% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free Sugar Free

Product Information

📋 Directions for Use

Suggested use: 1 to 2 capsules daily.

⚠️ Warnings & Precautions

Note: If you are pregnant, may become pregnant, or breastfeeding, consult your health care professional before using this product.

Do not use if tamper-evident seal is broken or missing.

Keep out of the reach of children.

🧪 Formulation Notes

Free form

L-Lysine is an essential free-form amino acid, which acts as a precursor for other amino acids, including L-carnitine (needed for fat metabolism). L-Lysine is crucial to the formation of collagen, a major part of the body's connective tissue. L-Lysine also contributes to energy production when converted to acetyl coenzyme A, one of the principal fuels for the Krebs Cycle.

Hypoallergenic: contains no yeast, dairy, egg, gluten, corn, soy or wheat.

Hypoallergenic: contains no yeast, dairy, egg, gluten, corn, soy or wheat. Contains no sugar, starch, salt, preservatives, or artificial color, flavor or fragrance.

Product Details

UPC / SKU 0 21078 01597 8
DSLD Entry Date 2023-08-23
Product Type Amino acid/Protein
Form Capsule
DSLD ID 295946
Data Updated 2026-04-11

Research Evidence

3 Research Sources
74 Avg Quality Score
3 Meta Analysis
A Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2026
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2016
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2013
View all evidence for Lysine →

Compare Similar Products

View all Lysine products →